If you are dealing with OAB symptoms, you may be eligible to participate in the PROTECT Study, a Multi-center, Prospective, Randomized, Controlled, Non-Inferiority, Clinical Trial of CAN-Stim of the Tibial Nerve versus Sacral Nerve Stimulation (SNS) in the treatment of Urinary Urgency Incontinence resulting from Refractory Overactive Bladder (OAB).
In this study, enrolled subjects are randomized 1:1 to receive either a StimGuard CAN-Stim or Medtronic InterStim® System. Subjects from both groups will immediately start with therapy. The primary endpoint is a ≥ 50% reduction in number of incontinence episodes associated with urgency at the 3-month visit, with additional measurements assessed at 14 days, 1, 6, 9 and 12-months.
Subjects will be recruited based on their ability to meet the inclusion/exclusion criteria.
For a complete list of the PROTECT Study inclusion/exclusion criteria, or to locate a clinical study site near you, please contact us.